IPO Deja Vu: Is It 1999 All Over Again?
- (0:30) - !999 IPO Mania
- (4:35) - How Does 2019 Compare?
- (9:10) - What Are The Risks With Having So many IPO’s?
- (15:50) - Is A Pintrest IPO Flying Under The Radar?
- (18:25) - Revisiting Popular 2018 IPO’s
- (28:30) - Episode Roundup: UBER, PINS, ZM, LYFT, SMAR, DOCU, DOMO, DBX, ZS, ZUO
Welcome to Episode #173 of the Zacks Market Edge Podcast.
Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life.
In this episode, Tracey is joined by Zacks Senior Strategist, Kevin Cook, to take a walk back into the past.
The Golden Year of the Dot-Com Boom
Remember the investing world in 1999?
Not only was the NASDAQ soaring but the IPO market was the hottest it had ever been.
In 1998 there were 363 deals and, in 1999, that jumped to an all-time record of 510 IPOs.
By comparison, in 2018, just 190 deals were done although 2018 was considered a “good” year.
By the end of 1999, it wasn’t unusual for some of the shares to have jumped over 400% since their launch. One of the big IPOs, VA Linux Systems, soared 698% in a matter of weeks.
Everyone wanted in, from grandmothers trading at their computers to institutional funds.
Now, flash forward to 2019, where a bunch of popular private technology companies are set to go public, such as Uber and Pinterest, many of them without any earnings.
Is this a replay of 1999 all over again?
Look at Last Year’s IPOs Instead
If you’re nervous about jumping into 2019’s batch of IPOs, why not take a look at 2018 before the Street got interested?
These companies have a track record now, with a couple of quarters of earnings reports under their belt.
What else should you know about the IPO boom and how to invest in it?
Listen to this week’s podcast to find out.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Click to get this free report
Domo, Inc. (DOMO): Free Stock Analysis Report
DocuSign Inc. (DOCU): Free Stock Analysis Report
Zscaler, Inc. (ZS): Free Stock Analysis Report
Dropbox, Inc. (DBX): Free Stock Analysis Report
Smartsheet Inc. (SMAR): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.